Literature DB >> 8908698

Direct identification of tumor-associated peptide antigens.

V H Engelhard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8908698     DOI： 10.1007/bf00820664

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  81 in total

Review 1.  Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes.

Authors:  J W Yewdell; J R Bennink
Journal:  Adv Immunol       Date:  1992       Impact factor: 3.543

2.  Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.

Authors:  S F Slovin; R D Lackman; S Ferrone; P E Kiely; M J Mastrangelo
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

3.  A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P G Coulie; F Lehmann; B Lethé; J Herman; C Lurquin; M Andrawiss; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

4.  Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.

Authors:  J P Klarnet; L A Matis; D E Kern; M T Mizuno; D J Peace; J A Thompson; P D Greenberg; M A Cheever
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

5.  Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes.

Authors:  W J Storkus; H J Zeh; M J Maeurer; R D Salter; M T Lotze
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

6.  Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumor.

Authors:  T M Blieden; A J McAdam; J G Frelinger; E M Lord
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

Review 7.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

Authors:  G E Peoples; P S Goedegebuure; R Smith; D C Linehan; I Yoshino; T J Eberlein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

9.  Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones.

Authors:  T Wölfel; W Herr; P Coulie; U Schmitt; K H Meyer zum Büschenfelde; A Knuth
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

10.  A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Authors:  C Traversari; P van der Bruggen; I F Luescher; C Lurquin; P Chomez; A Van Pel; E De Plaen; A Amar-Costesec; T Boon
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307
View more
  1 in total

1.  Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo.

Authors:  A L Zarling; S B Ficarro; F M White; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.